NVO (NYSE) - Novo Nordisk A/S

Exchange: USA Stocks • Country: USA • Currency: USD • Type: Common Stock • ISIN: US6701002056
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Web URL: https://www.novonordisk.com

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for NVO (NYSE) - Novo Nordisk A/S
  • Uncommon Growth Rate
Market Cap. 373,997m USD
Enterprise Value 399,515m USD (+6%)
GiC Sector Health Care
GiC Group Pharmaceuticals, Biotechnology & Life Sciences
GiC Industry Pharmaceuticals
GiC SubIndustry Pharmaceuticals
TER 0.00%
IPO / Inception 1982-01-04


Fundamental 9.07
Dividend 7.49
Technical 9.24
Performance 5.18
Analysts 3.75
Price / Fair Price TR 0.91
Price / Fair Price DCF todo


Growth TTM 54.93%
CAGR 5y 30.79%
CAGR / Mean Drawdown 5y 5.86
Sharpe Ratio TTM 1.74
Alpha vs SP500 TTM 51.28
Beta vs SP500 5y weekly 0.68
Volatility GJR Garch 1y 28.31%
CAPM 8.31%
Correlation TTM 0.69
Max Drawdown 5y 24%
Mean Drawdown 5y 5.3%
Price / SMA 200 days -19.48%
Current Volume 962.4k
Average Volume 1451.8k


Rate TTM 1.76
Yield TTM 1.08%
Div. CAGR 5y 7.81%
Consistency of Dividends all time 96.5%